| http://www.w3.org/ns/prov#value | - Maximum Tolerated Dose (MTD) [ Time Frame: Each patient will be followed for 22 days ] [ Designated as safety issue: Yes ]Patients will be sequentially assigned to increasing doses of Dexanabinol, to establish the MTD (highest dose it is safe to give patients) or alternatively the Maximum Administered Dose(MAD).
|
